Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

Background: New direct-acting antiviral agents for hepatitis C genotype 1 infection, boceprevir and telaprevir, offer enhanced sustained virologic response (SVR) among both treatment-naïve and treatment-experienced patients. Aim: To determine the relative efficacy of the new direct-acting antiviral...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cooper, C., Lester, R., Thorlund, K., Druyts, E., El Khoury, A.C., Yaya, S., Mills, E.J.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Original Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3550598/
https://ncbi.nlm.nih.gov/pubmed/23159839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/qjmed/hcs214
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars